Sigrid Fischer

Mrs. Sigrid Fischer


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Pain Medicine
Verified
Journal Article
Closed access
PDF file
SFSigrid Fischer
Sigrid Fischer
SCSusan Collins
Susan Collins
SBSabine Boogaard
Sabine Boogaard
SLStephan A. Loer
Stephan A. Loer
WZWouter W. A. Zuurmond
Wouter W. A. Zuurmond
RPRoberto S. G. M. Perez
Roberto S. G. M. Perez

Verified
Journal Article
Open access
PDF file
SFSigrid Fischer
Sigrid Fischer
RPRoberto S. G. M. Perez
Roberto S. G. M. Perez
JNJan Nouta
Jan Nouta
WZWouter W. A. Zuurmond
Wouter W. A. Zuurmond
PSPeter G. Scheffer
Peter G. Scheffer
Exaggerated inflammation and oxidative stress are involved in the pathogenesis of Complex Regional Pain Syndrome (CRPS). However, studies assessing markers for oxidative stress in CRPS patients are limited. In this study, markers for lipid peroxidation (malondialdehyde and F2-isoprostanes) and DNA damage (8-hydroxy-2-deoxyguanosine) were measured in nine patients (mean age 50.1 ± 17.1 years) with short term CRPS-1 (median 3 months) and nine age and sex matched healthy volunteers (mean age 49.3 ± 16.8 years) to assess and compare the level of oxidative stress. No differences were found in plasma between CRPS patients and healthy volunteers for malondialdehyde (5.2 ± 0.9 µmol/L vs. 5.4 ± 0.5 µmol/L) F2-isoprostanes (83.9 ± 18.7 pg/mL vs. 80.5 ± 12.3 pg/mL) and 8-hydroxy-2-deoxyguanosine (92.6 ± 25.5 pmol/L vs. 86.9 ± 19.0 pmol/L). Likewise, in urine, no differences were observed between CRPS patients and healthy volunteers for F2-isoprostanes (117 ng/mmol, IQR 54.5–124.3 vs. 85 ng/mmol, IQR 55.5–110) and 8-hydroxy-2-deoxyguanosine (1.4 ± 0.7 nmol/mmol vs. 1.4 ± 0.5 nmol/mmol). Our data show no elevation of systemic markers of oxidative stress in CRPS patients compared to matched healthy volunteers. Future research should focus on local sampling methods of oxidative stress with adequate patient selection based on CRPS phenotype and lifestyle.